#$%^&*AU2020205268A120200806.pdf#####ABSTRACT Disclosed herein are compositions and methods for treating depression using compositions comprising a compound of formula I. Disclosed herein are compositions and methods for treating depression using compositions comprising phenoxypropylamine compounds and 5 derivatives having selective affinity for and antagonistic activity against the 5-HTIA receptor, as well as 5-HT reuptake inhibitory activity. In addition, compositions and methods for treating depression using compositions comprising a compound of formula II are disclosed. Methods of treating or diminishing at least one symptom of depression in a human subject with a composition comprising a compound of the formula (I) or formula (II), or a pharmaceutically [0 acceptable salt, hydrate, or solvate thereof, are also disclosed.
